Cart
sales@molnova.com
Leonurine hydrochloride
CAS No. 24735-18-0
Leonurine hydrochloride( SCM-198 hydrochloride )
Catalog No. M17452 CAS No. 24735-18-0
Leonurine (hydrochloride), a major alkaloid compound extracted from?Leonurus japonicas?Houtt. (Labiatae), is considered to have antitumor roles.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 47 | Get Quote |
|
| 10MG | 71 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLeonurine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionLeonurine (hydrochloride), a major alkaloid compound extracted from?Leonurus japonicas?Houtt. (Labiatae), is considered to have antitumor roles.
-
DescriptionLeonurine (hydrochloride), a major alkaloid compound extracted from?Leonurus japonicas?Houtt. (Labiatae), is considered to have antitumor roles.
-
In Vitro——
-
In Vivo——
-
SynonymsSCM-198 hydrochloride
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorTLR
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number24735-18-0
-
Formula Weight347.79
-
Molecular FormulaC14H22ClN3O5
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 31 mg/mL; 89.13 mM
-
SMILESCOc1cc(cc(c1O)OC)C(=O)OCCCCNC(=N)N.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mao F, et al. Leonurine hydrochloride induces apoptosis of H292 lung cancer cell by a mitochondria-dependent pathway. Pharm Biol. 2015;53(11):1684-90.
molnova catalog
related products
-
Icotinib
Icotinib is a potent and specific EGFR inhibitor with IC50 of 5 nM.
-
AG-825
AG-825（Tyrphostin C15） is a selective and competitive ErbB2 inhibitor that inhibits tyrosine phosphorylation with an IC50 value of 0.35 μM.AG-825 (Tyrphostin C15) inhibits HER2 and shows anticancer activity in a mouse xenograft model of breast cancer.
-
EGF816 mesylate
EGF816 (Nazartinib) is a potent, irreversible, mutant-selective EGFR inhibitor with Ki and Kinact of 31 nM and 0.222 min-1, respectively.
